Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05198154Recruiting

ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Role: collaborator

NCT04074538Recruiting

the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium

Role: collaborator

NCT02613013Not ApplicableUnknown

Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle Closure

Role: collaborator

NCT02689583Not ApplicableUnknown

A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection

Role: collaborator

NCT02503943Phase 4Unknown

Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes

Role: lead

All 5 trials loaded